Mostrar el registro sencillo del ítem

dc.contributor.authorTorres-Martos, Álvaro
dc.contributor.authorAnguita-Ruiz, Augusto
dc.contributor.authorBustos-Aibar, Mireia
dc.contributor.authorRamírez-Mena, Alberto
dc.contributor.authorArteaga, María
dc.contributor.authorBueno, Gloria
dc.contributor.authorLeis, Rosaura
dc.contributor.authorAguilera García, Concepción María 
dc.contributor.authorAlcalá Fernández, Rafael 
dc.contributor.authorAlcalá-Fdez, Jesús
dc.date.accessioned2024-09-02T11:06:23Z
dc.date.available2024-09-02T11:06:23Z
dc.date.issued2024
dc.identifier.citationTorres-Martos, Á., Anguita-Ruiz, A., Bustos-Aibar, M., Ramírez-Mena, A., Arteaga, M., Bueno, G., Leis, R., Aguilera, C. M., Alcalá, R., & Alcalá-Fdez, J. (2024). Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study. Artificial intelligence in medicine, 156, 102962. https://doi.org/10.1016/j.artmed.2024.102962es_ES
dc.identifier.urihttps://hdl.handle.net/10481/93775
dc.descriptionSupplementary Material: https://sci2s.ugr.es/MultiOmics_IR_Predes_ES
dc.description.abstractPediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systemses_ES
dc.description.sponsorshipThis research was supported by the Instituto de Salud Carlos III cofunded by the European Union and ERDF A way of making Europe (grant numbers PI20/00711, PI20/00563, PI20/00924, P20/00988, PI23/00028, PI23/00129, PI23/01032, PI23/00165 and also PI23/00191), and by the European Union through the Horizon Europe Framework Programme (eprObes project, grant number GA 101080219). The authors also acknowledge Instituto de Salud Carlos III for personal funding of A.A.R, A.T.M and M.B.A.: i-PFIS and PFIS contracts: IIS doctorates - company in health sciences and technologies of the Strategic Health Action (IFI17/00048, IFI22/00013 and FI23/00042). We also thank the support from the grant FJC2021- 046952-I by Ministerio de Ciencia, Innovación y Universidades y Agencia Estatal de Investigación.. Funding for open access charge: Universidad de Granada/CBUA.es_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPediatric obesityes_ES
dc.subjectInsulin resistancees_ES
dc.subjectEpigenomicses_ES
dc.subjectMultiomicses_ES
dc.subjectMachine Learninges_ES
dc.subjectExplainable Artificial Intelligencees_ES
dc.titleMultiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal studyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.artmed.2024.102962
dc.type.hasVersionAMes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional